Avaleht › Ülekaalulisus › South Carolina

Ülekaalulisus kliinilised uuringud osariigis South Carolina

35 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid osariigis South Carolina.

Linnad osariigis South Carolina

Ametlik uuringutekst (inglise keeles)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Spartanburg Medical Research, Spartanburg

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Prisma Health-Ped Endo, Greenville
Coastal Carolina Research Ctr, North Charleston

VärbamineFaas 3

Vanused 8–18 · Kõik sood · Uuendatud 30. sept 2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Tribe Clinical Research, Greenville

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Medical Uni of SC Charleston, Charleston
Coastal Carolina Research Ctr, North Charleston
Hillcrest Clinical Research, Simpsonville
ja veel 1

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Medical University Of South Carolina, Charleston
Hillcrest Clinical Research, Simpsonville
Spartanburg Medical Research, Spartanburg

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Care Access - Mauldin, Mauldin

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastroenterology Associates - Patewood, Greenville

VärbamineFaas 3

Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Coastal Pediatric Associates, Charleston
Medical University of South Carolina Children Hospital - PIN, Charleston

VärbamineFaas 3

Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Associates - Patewood, Greenville

VärbamineFaas 3

Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Accellacare - Mt Pleasant, Mt. Pleasant

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Trial Management Associates, Myrtle Beach

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Bogan Sleep Consultants, Columbia

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Accellacare Charleston, Mt. Pleasant

VärbamineFaas 3

Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Tribe Clinical Research, LLC, Greenville
Accellacare - Mt Pleasant, Mt. Pleasant

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Tribe Clinical Research, LLC, Greenville

VärbamineFaas 2

Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Bluffton
AURORA-1 Clinical Site, Clemson
AURORA-1 Clinical Site, Columbia
ja veel 1

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Bluffton
AURORA-2 Clinical Site, Clemson
AURORA-2 Clinical Site, Columbia
ja veel 1

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Coastal Carolina Research Center, North Charleston

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Trial Management Associates, Myrtle Beach

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Greer

VärbamineFaas 3Terved vabatahtlikud oodatud

Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Spartanburg Medical Research, Spartanburg

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07770841

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Bogan Sleep Consultants, LLC, Columbia

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Tribe Clinical Research, LLC, Greenville

VärbamineFaas 2

Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Columbia Dermatology & Aesthetics, Columbia

VärbamineFaas 4

Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Coastal Carolina Res Ctr, North Charleston

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Spartanburg

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Tribe Clinical Research LLC Dba Mountain View Clinical Research, Greenville

VärbamineFaas 3

Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Mauldin

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284875

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Greer

VärbamineFaas 3

Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Coastal Carolina Research Ctr, North Charleston

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. juuni 2026 · NCT07607587

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Monroe Biomedical Research, North Charleston

VärbamineFaas 2

Vanused 18–60 · Kõik sood · Uuendatud 22. juuni 2026 · NCT07570758

Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

University of South Carolina, Columbia

VärbamineTerved vabatahtlikud oodatud

Vanused 3–5 · Kõik sood · Uuendatud 11. juuni 2026 · NCT07583459

Pistachio Snacking and Metabolic Flexibility

Public Health Research Center: Clinical Exercise Research Center, Columbia

VärbamineTerved vabatahtlikud oodatud

Vanused 25–45 · Kõik sood · Uuendatud 14. jaan 2026 · NCT07340125

Optimal Digital Weight Loss Treatment for Rural Individuals

University of South Carolina, Columbia

VärbamineTerved vabatahtlikud oodatud

Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. dets 2025 · NCT06105957

Fueling Strong Hearts for a Strong South Carolina

Pee Dee Research and Education Center, Florence

Värbamine

Vanused 45–80 · Kõik sood · Uuendatud 26. aug 2025 · NCT07140952

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.